Barely Significant
← all phrases

“a nonsignificant trend”

5,407 sentences · 5,407 papers · 7,516 search hits before verification · confirmed specimen

Sighted at

p<0.1

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

a nonsignificant trendP = .0681.4× alphagold
Although there was a nonsignificant trend toward patients with lymph node-only disease receiving LRT in higher proportion (37% vs. 21.5%; P = .068), no differences were observed in patients with visceral (22.7% vs. 26.7%; P = .725) or bone-only (28.7% vs. 20.5%; P = .125) metastases.
a nonsignificant trendP = 0.0681.4× alphagold
Functional improvement was also observed in subscales of SDS; the SDS-social life subscore ( P = 0.003) and the SDS-family life/home responsibilities subscore (P = 0.003) were improved significantly when compared with the placebo group, and there was a nonsignificant trend towards improvement on the SDS-work/school subscore ( P = 0.068).
Lurasidone as a potential therapy for bipolar disorder.
Neuropsychiatr Dis Treat · 2013 · PMC3797281
a nonsignificant trendp = 0.0681.4× alphagold
When analyzing the evolution of malnutrition risk according to the degree of adherence to the digital nutritional program, patients with a higher percentage of adherence showed greater MUST score improvement at 24 weeks compared with those with lower adherence ( p = 0.045), while at 12 weeks a nonsignificant trend was observed ( p = 0.068).
a nonsignificant trendP = 0.0681.4× alphagold
We found no difference in the protein levels of MFN1 ( P = 0.753) and MFN2 ( P = 0.852) between all groups, while OPA1 exhibited a nonsignificant trend to decrease in the high glucose group compared with the normal group( P = 0.068) but increase in the high glucose plus group compared with the high glucose group ( P = 0.064) (Figure S2 ). 3.6.
a nonsignificant trendP =0.0691.4× alphagold
atrial fibrillation bleeding risk clinical risk scores Subject Categories Atrial Fibrillation Prognosis Anticoagulants Quality and Outcomes For GARFIELD‐AF risk categories, the high‐score category showed a nonsignificant trend for major bleeding in the higher‐risk category compared with the low‐score category ( P =0.069), whereas for the major/CRNM bleeding outcome, the high‐score category had a significantly greater risk than the low‐score category ( P =0.013) (Figure 1 , bottom panels).
a nonsignificant trendP = .0691.4× alphagold
In the mUC-non-EV cohort (ClinicalTrials.gov identifiers: NCT01855477 and NCT02925234 ), 27 of 27 patients with NECTIN4 amplification were male ( P = .001), and again, there was a nonsignificant trend toward a higher frequency of NECTIN4 amplification in older patients with mUC ( P = .069; Appendix Table A 2 ).